Supramolecular nanofibers co-loaded with dabrafenib and doxorubicin for targeted and synergistic therapy of differentiated thyroid carcinoma.

Theranostics · 2023 · PMC10157742 · PMID 37153748

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Therefore, the design of targeted and effective carrier systems is highly significant for the safe and efficient combination of Dox and BRAF V600E inhibitors for DTC therapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.